Global Optical Genome Mapping Market Insights Forecasts to 2033

• The Global Optical Genome Mapping Market Size was Valued at USD 107.5 Million in 2023
• The Market Size is Growing at a CAGR of 29.27% from 2023 to 2033
• The Worldwide Optical Genome Mapping Market Size is Expected to Reach USD 1400.5 Million by 2033
• Europe is Expected to Grow the fastest during the forecast period.

The Global Optical Genome Mapping Market Size is Anticipated to Exceed USD 1400.5 Million by 2033, Growing at a CAGR of 29.27% from 2023 to 2033.

Market Overview

Optical genome mapping (OGM) is an innovative cytogenomic technology for analyzing large eukaryotic genomes and structural chromosomal features at a high level of resolution. OGM has emerged as a complementary approach, and offers a unique perspective on the genome's architecture, ultimately providing critical information in genetics research. It can produce nearly error-free assemblies from isolated linearized DNA fragments (∼100 kb) to capture disease-relevant SVs and repeat architecture across the human genome. It is also used for the diagnosis of a rare genetic muscle disease facioscapulohumeral muscular dystrophy (FSHD). It has been suggested for use as a cytogenomic tool for prenatal diagnostics and provides important information for prenatal decision-making and genetic counseling by detecting genomic alterations in cell cultures from prenatal samples. It is emerging as a powerful tool for cancer research by using OGM-based 5-hmC mapping shows a promising potential for cancer diagnostics. The integration of omics technology like genomics, epigenomics and transcriptomics, provides a comprehensive understanding of the genome, leading to insights into disease mechanisms. The intersection of optical genome mapping (OGM) and personalized medicine holds immense promise for the future of healthcare.

Report Coverage

This research report categorizes the market for the global optical genome mapping market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global optical genome mapping market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global optical genome mapping market.

Driving Factors

The incorporation of optical genome mapping into precision medicine, drug development, and testing, leveraging its ability to detect structural differences and improve genomic analysis, and the strong presence of leading biotechnology and pharmaceutical companies are augmenting the market growth for optical genomic mapping. The extensive government funding by the Ministry of Science and Technology, Government of India, Canadian Institutes of Health Research, Genomics Health Futures Mission (Australian Government Department of Health and Aged Care), Genomics England for genomics research, and other organizations across the globe to improve testing and diagnosis of various rare, serious and chronic genetic diseases, personalized treatment for improved health outcome, and creation of genome library to make genomic research more sustainable, secure, and equitable. Further, increasing demand for advanced genomic analysis tools and techniques for understanding genetic diseases and facilitates personalized medicine. The continuous advancements in optical mapping technologies. In addition, the adoption of optical genome mapping in research institutions and pharmaceutical companies contributed to driving the optical genome mapping market.

Restraining Factors

The use of sophisticated laboratory equipment and instruments for mapping and analyzing genomes at a much larger scale. These instruments are extremely expensive and cost upwards of hundreds of thousands of dollars. Further, the high capital investment required for small to medium-scale clinical laboratories and research institutes, especially in developing countries restraining the market. The stringent regulations around the ethical and legal use of genomics data for protecting privacy and preventing misuse and the need for extensive validation and documentation for compliance with different regulatory frameworks increase the cost and complexity of market players leading to restrain the market.

Market Segmentation

The global optical genome mapping market share is classified into product, application, and end-user.

• The services segment dominated the market with the largest revenue share in 2023.

Based on the product, the global optical genome mapping market is categorized into instruments, consumables & reagents, software, and services. Among these, the services segment dominated the market with the largest revenue share in 2023. The OGM services including customized services like data processing and interpretation during optical genome mapping provide tailored solutions to meet specific research or clinical needs with accurate reading and results. It also provides valuable insights into the formulation, implementation, and analysis of OGM. The increasing number of outsourced service vendors is anticipated to drive the market.

• The structural variant segment accounted for the largest revenue share of the global optical genome mapping market during the forecast period.

Based on the application, the global optical genome mapping market is categorized into structural variant detection, genome assembly, microbial strain typing, and others. Among these, the structural variant segment accounted for the largest revenue share of the global optical genome mapping market during the forecast period. Optical genome mapping is a highly promising method to detect all types of structural variations in the genome as next-generation cytogenetics in human genomes, supporting accurate disease diagnosis and prognosis, aiding in characterizing cancer subtypes, predicting patient outcomes, and guiding targeted therapies. The increasing research on large-scale genome identification and the usage of OGM is anticipated to drive the market. 

• The academic research institutes segment held the largest share of the global optical genome mapping market in 2023.   

Based on the end-user, the global optical genome mapping market is categorized into biotechnology and pharmaceutical companies, clinical laboratories, academic research institutes, and others. Among these, the academic research institutes segment held the largest share of the global optical genome mapping market in 2023. Academic research institutes have adopted OGM technologies, conducting studies, and experiments. They play a vital role in training the next generation of scientists, researchers, and genomic experts, offering educational programs, courses, and workshops.

Regional Segment Analysis of the Global Optical Genome Mapping Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global optical genome mapping market over the predicted timeframe.

North America is projected to hold the largest share of the global optical genome mapping market over the forecast period. The presence of several research institutes, universities, and academic centers in the region for conducting genomic research is contributing to market growth. The emphasis on the R&D of genomics and financial support for the R&D activities of optical genome mapping is augmenting the market growth. Furthermore, the increasing prevalence of genetic diseases augments market demand for optical genome mapping.

Europe is expected to grow at the fastest CAGR growth of the global market during the forecast period. The growing emphasis on genomic research and technologies by the key market players in the region is driving the market demand for optical genome mapping. The increasing focus on precision medicine, companion diagnostics, and advancement in genome analysis techniques are further driving the optical genome mapping market in the region. The adoption and the use of optical genome mapping by hospitals are expected to drive the market. 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global optical genome mapping market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Bionano Genomics
• Nucleome Informatics Private Limited
• PerkinElmer (PerkinElmer Genomics)
• Praxis Genomics, LLC
• OpGen
• Nabsys
• Genohub Inc.
• SourceBio International Limited (Source BioScience)
• MedGenome
• INRAE (French Plant Genomic Resources Center (CNRGV))
• Hofkens Lab
• Cerba Healthcare
• Illumina Inc.
• Oxford Nanopore Technologies
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In July 2023, Bionano Genomics, Inc. announced the Stratys system for high throughput optical genome mapping (OGM) and VIA software for visualization, interpretation, and reporting of genome analysis for OGM, microarrays, and next-generation sequencing (NGS) data in one integrated software platform. VIA further incorporated these data into an intuitive and powerful workflow for hematologic malignancies.

• In June 2022, Arima Genomics, Inc., the leader in 3D genomics, announced the launch of the Arima Library Prep Module. The launch of the Arima Library Prep Module provides customers with a robust, end-to-end 3D genomics protocol based on a well-established Hi-C workflow, enabled them to unlock new insights for disease research, genome assembly, and other research applications.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global optical genome mapping market based on the below-mentioned segments: 

Global Optical Genome Mapping Market, By Product

• Instruments
• Consumables & Reagents
• Software
• Services

Global Optical Genome Mapping Market, By Application

• Structural Variant Detection
• Genome Assembly
• Microbial Strain Typing
• Others

Global Optical Genome Mapping Market, By End-User

• Biotechnology and Pharmaceutical Companies
• Clinical Laboratories
• Academic Research Institutes
• Others

Global Optical Genome Mapping Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa